AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Inhibition Of Sars-Associated Coronavirus (Scov) Infection And Replication By Rna Interference

Summary: The Present Invention Relates To Therapeutic Agents Useful For The Treatment Of Severe Acute Respiratory Syndrome (Sars) In Humans. In Particular, The Present Invention Relates To Rna Interference (Rnai) Molecules Useful For Inhibiting The Infection And Replication Of Hsars Virus. Preferably, The Rnai Molecules Target The Replicase Region Of The Hsars Virus, Or Combinations Of Different Sites Of Hsars Virus Genes. The Present Invention Further Encompasses Methods Of Using The Rnai Molecules For Preventing And/Or Treating Sars. Vaccines And Kits Comprising Therapeutically Effective Amounts Of The Rnai Molecules Are Also Encompassed.

Application No.: US2006452267A

Country/Region: Hong Kong

For more information, please click Here